{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:42:08Z","timestamp":1790628128716,"version":"4.1.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with multiple myeloma (MM) who are treated with lenalidomide rarely develop a secondary B-cell acute lymphoblastic leukemia (B-ALL). The clonal and biological relationship between these sequential malignancies is not yet clear. We identified 17 patients with MM treated with lenalidomide, who subsequently developed B-ALL. Patient samples were evaluated through sequencing, cytogenetics\/fluorescence in situ hybridization (FISH), immunohistochemical (IHC) staining, and immunoglobulin heavy chain (IgH) clonality assessment. Samples were assessed for shared mutations and recurrently mutated genes. Through whole exome sequencing and cytogenetics\/FISH analysis of 7 paired samples (MM\u00a0vs matched B-ALL), no mutational overlap between samples was observed. Unique dominant IgH clonotypes between the tumors were observed in 5 paired MM\/B-ALL samples. Across all 17 B-ALL samples, 14 (83%) had a TP53 variant detected. Three MM samples with sufficient sequencing depth (&amp;gt;500\u00d7) revealed rare cells (average of 0.6% variant allele frequency, or 1.2% of cells) with the same TP53 variant identified in the subsequent B-ALL sample. A lack of mutational overlap between MM and B-ALL samples shows that B-ALL developed as a second malignancy arising from a founding population of cells that likely represented unrelated clonal hematopoiesis caused by a TP53 mutation. The recurrent variants in TP53 in the B-ALL samples suggest a common path for malignant transformation that may be similar to that of TP53-mutant, treatment-related acute myeloid leukemia. The presence of rare cells containing TP53 variants in bone marrow at the initiation of lenalidomide treatment suggests that cellular populations containing TP53 variants expand in the presence of lenalidomide to increase the likelihood of B-ALL development.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022007496","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T13:47:10Z","timestamp":1666014430000},"page":"236-245","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":24,"title":["Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1631-1201","authenticated-orcid":false,"given":"Erica K.","family":"Barnell","sequence":"first","affiliation":[{"name":"1McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"},{"name":"2Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1928-7139","authenticated-orcid":false,"given":"Zachary L.","family":"Skidmore","sequence":"additional","affiliation":[{"name":"1McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"},{"name":"2Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7034-498X","authenticated-orcid":false,"given":"Kenneth F.","family":"Newcomer","sequence":"additional","affiliation":[{"name":"3Department of Surgery, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5317-3867","authenticated-orcid":false,"given":"Monique","family":"Chavez","sequence":"additional","affiliation":[{"name":"4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6491-4432","authenticated-orcid":false,"given":"Katie M.","family":"Campbell","sequence":"additional","affiliation":[{"name":"1McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"},{"name":"2Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0890-6889","authenticated-orcid":false,"given":"Kelsy C.","family":"Cotto","sequence":"additional","affiliation":[{"name":"1McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"},{"name":"2Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5873-351X","authenticated-orcid":false,"given":"Nicholas C.","family":"Spies","sequence":"additional","affiliation":[{"name":"1McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"},{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0833-8335","authenticated-orcid":false,"given":"Marianna B.","family":"Ruzinova","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8463-2720","authenticated-orcid":false,"given":"Tianjiao","family":"Wang","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8047-1894","authenticated-orcid":false,"given":"Brooj","family":"Abro","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7610-6480","authenticated-orcid":false,"given":"Friederike","family":"Kreisel","sequence":"additional","affiliation":[{"name":"6Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2490-8294","authenticated-orcid":false,"given":"Bijal A.","family":"Parikh","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4199-8906","authenticated-orcid":false,"given":"Eric J.","family":"Duncavage","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4614-681X","authenticated-orcid":false,"given":"John L.","family":"Frater","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Shan","family":"Lee","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjum","family":"Hassan","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"King","sequence":"additional","affiliation":[{"name":"4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Kohnen","sequence":"additional","affiliation":[{"name":"4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0208-5023","authenticated-orcid":false,"given":"Mark A.","family":"Fiala","sequence":"additional","affiliation":[{"name":"4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6656-3672","authenticated-orcid":false,"given":"John S.","family":"Welch","sequence":"additional","affiliation":[{"name":"4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7809-0996","authenticated-orcid":false,"given":"Geoffrey L.","family":"Uy","sequence":"additional","affiliation":[{"name":"4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"7Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3633-0565","authenticated-orcid":false,"given":"Kiran","family":"Vij","sequence":"additional","affiliation":[{"name":"4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8795-3610","authenticated-orcid":false,"given":"Ravi","family":"Vij","sequence":"additional","affiliation":[{"name":"4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"7Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6388-446X","authenticated-orcid":false,"given":"Malachi","family":"Griffith","sequence":"additional","affiliation":[{"name":"1McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"},{"name":"4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"7Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"},{"name":"8Department of Genetics, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0843-4271","authenticated-orcid":false,"given":"Obi L.","family":"Griffith","sequence":"additional","affiliation":[{"name":"1McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"},{"name":"4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"7Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"},{"name":"8Department of Genetics, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas D.","family":"Wartman","sequence":"additional","affiliation":[{"name":"4Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"7Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"},{"name":"9Department of Pediatrics, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2023013115350714900_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol"},{"issue":"14","key":"2023013115350714900_bib2","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","article-title":"Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma","volume":"376","author":"Attal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"2023013115350714900_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/joim.12590","article-title":"Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes","volume":"281","author":"Landgren","year":"2017","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"2023013115350714900_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Fran\u00e7ais du My\u00e9lome","volume":"335","author":"Attal","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"2023013115350714900_bib5","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2011-08-373514","article-title":"A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide","volume":"119","author":"Dimopoulos","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2023013115350714900_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/annonc\/mdw606","article-title":"Second primary malignancies in multiple myeloma: an overview and IMWG consensus","volume":"28","author":"Musto","year":"2017","journal-title":"Ann Oncol"},{"issue":"29","key":"2023013115350714900_bib7","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1200\/JCO.2017.72.6679","article-title":"Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis","volume":"35","author":"McCarthy","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"2023013115350714900_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/bjh.15426","article-title":"Second primary malignancy after multiple myeloma-population trends and cause-specific mortality","volume":"182","author":"Costa","year":"2018","journal-title":"Br J Haematol"},{"issue":"16","key":"2023013115350714900_bib9","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/cncr.26735","article-title":"Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis","volume":"118","author":"Abdulwahab","year":"2012","journal-title":"Cancer"},{"issue":"6","key":"2023013115350714900_bib10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3324\/haematol.2011.057752","article-title":"Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?","volume":"97","author":"Tang","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"2023013115350714900_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41375-018-0213-y","article-title":"Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma","volume":"33","author":"Aldoss","year":"2019","journal-title":"Leukemia"},{"issue":"7","key":"2023013115350714900_bib12","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/s41375-020-01061-9","article-title":"Therapy-related B-cell acute lymphoblastic leukemia in adults has unique genetic profile with frequent loss of TP53 and inferior outcome","volume":"35","author":"Barnea Slonim","year":"2020","journal-title":"Leukemia"},{"issue":"14","key":"2023013115350714900_bib13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJM197910043011402","article-title":"The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia","volume":"301","author":"Bergsagel","year":"1979","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"2023013115350714900_bib14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0002-9343(74)90171-5","article-title":"Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature","volume":"57","author":"Rosner","year":"1974","journal-title":"Am J Med"},{"issue":"1","key":"2023013115350714900_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beha.2019.02.007","article-title":"Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome","volume":"32","author":"Chua","year":"2019","journal-title":"Best Pract Res Clin Haematol"},{"issue":"12","key":"2023013115350714900_bib16","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3109\/10428194.2013.786072","article-title":"Acute lymphoblastic leukemia developing during maintenance therapy with lenalidomide in a patient with multiple myeloma","volume":"54","author":"Garc\u00eda-Mu\u00f1oz","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2023013115350714900_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hon.2248","article-title":"Lenalidomide and secondary acute lymphoblastic leukemia: a case series","volume":"35","author":"Tan","year":"2017","journal-title":"Hematol Oncol"},{"key":"2023013115350714900_bib18","first-page":"9052314","article-title":"Acute lymphoblastic leukemia following lenalidomide maintenance for multiple myeloma: two cases with unexpected presentation and good prognostic features [published correction appears in Case Rep Hematol. 2019;1548610].","volume":"2018","author":"Khan","year":"2018","journal-title":"Case Rep Hematol"},{"issue":"7540","key":"2023013115350714900_bib19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature"},{"issue":"22","key":"2023013115350714900_bib20","first-page":"2059","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia [erratum appears in: N Engl J Med. 2013;369(1):98]","volume":"368","author":"Ley","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"2023013115350714900_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/gm492","article-title":"A SNP profiling panel for sample tracking in whole-exome sequencing studies","volume":"5","author":"Pengelly","year":"2013","journal-title":"Genome Med"},{"key":"2023013115350714900_bib22","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gkj144","article-title":"The UCSC Genome Browser Database: update 2006","volume":"34","author":"Hinrichs","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"2023013115350714900_bib23","article-title":"Bam-readcount -- rapid generation of basepair-resolution sequence metrics","author":"Khanna","year":"27  2021","journal-title":"ArXiv"},{"issue":"21","key":"2023013115350714900_bib24","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","article-title":"Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads","volume":"25","author":"Ye","year":"2009","journal-title":"Bioinformatics"},{"issue":"17","key":"2023013115350714900_bib25","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/bioinformatics\/btp373","article-title":"VarScan: variant detection in massively parallel sequencing of individual and pooled samples","volume":"25","author":"Koboldt","year":"2009","journal-title":"Bioinformatics"},{"issue":"3","key":"2023013115350714900_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"8","key":"2023013115350714900_bib27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat Methods"},{"issue":"9","key":"2023013115350714900_bib28","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"issue":"4","key":"2023013115350714900_bib29","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41436-018-0278-z","article-title":"Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples","volume":"21","author":"Barnell","year":"2019","journal-title":"Genet Med"},{"key":"2023013115350714900_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1200\/PO.20.00182","article-title":"Impact of a 40-gene targeted panel test on physician decision making for patients with acute myeloid leukemia","author":"Barnell","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"D1","key":"2023013115350714900_bib31","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"6453","key":"2023013115350714900_bib32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1126\/science.aax3649","article-title":"A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies","volume":"365","author":"Boettcher","year":"2019","journal-title":"Science"},{"issue":"8","key":"2023013115350714900_bib33","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.3324\/haematol.2018.205302","article-title":"TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies","volume":"104","author":"Ruzinova","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"2023013115350714900_bib34","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1186\/s12885-019-6286-9","article-title":"B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review","volume":"19","author":"Sinit","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"2023013115350714900_bib35","first-page":"44","article-title":"Current status of autologous stem cell transplantation for multiple myeloma","volume":"9","author":"Al Hamed","year":"2019","journal-title":"Blood\u00a0Cancer J"},{"issue":"19","key":"2023013115350714900_bib36","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1056\/NEJMoa1114138","article-title":"Lenalidomide maintenance after stem-cell transplantation for multiple myeloma","volume":"366","author":"Attal","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"2023013115350714900_bib37","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajcp\/aqaa109","article-title":"Lenalidomide-associated secondary B-lymphoblastic leukemia\/lymphoma-a unique entity","volume":"154","author":"Germans","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2023013115350714900_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood-2014-02-558833","article-title":"TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis","volume":"124","author":"Stengel","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2023013115350714900_bib39","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.3324\/haematol.2012.076786","article-title":"TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy","volume":"98","author":"Chiaretti","year":"2013","journal-title":"Haematologica"},{"issue":"4","key":"2023013115350714900_bib40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mc.10159","article-title":"TP53 is frequently altered by methylation, mutation, and\/or deletion in acute lymphoblastic leukaemia","volume":"38","author":"Agirre","year":"2003","journal-title":"Mol Carcinog"},{"issue":"4","key":"2023013115350714900_bib41","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.3324\/haematol.2017.181404","article-title":"Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide","volume":"103","author":"Lod\u00e9","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"2023013115350714900_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/bjh.12354","article-title":"Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations","volume":"162","author":"Mallo","year":"2013","journal-title":"Br J Haematol"},{"issue":"3","key":"2023013115350714900_bib43","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1182\/blood-2008-04-149286","article-title":"Patients\u2019 age and BCR-ABL frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group","volume":"112","author":"Burmeister","year":"2008","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/2\/236\/2031534\/blooda_adv-2022-007496-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/2\/236\/2031534\/blooda_adv-2022-007496-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T11:13:04Z","timestamp":1675163584000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/2\/236\/486813\/Distinct-clonal-identities-of-B-ALLs-arising-after"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007496","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]}}}